Aruna Gambhir is CEO of CellSight Technologies, a clinical stage biotech company based in San Francisco. CellSight is commercialising imaging technologies licensed from Stanford with funding from NCI and various pharmaceutical companies. Previously she was an executive with Siebel Systems and helped it grow from startup to Fortune 500. She was an early employee at Gain Technology which was acquired by Sybase. Her experience spans startups, academia, non-profit foundations and advocacy groups. Gambhir has a BA in biochemistry from UC Berkeley; an MS in computer science from Santa Clara University; and an MBA from UCLA.